Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
1.425
-0.165 (-10.38%)
Mar 31, 2025, 1:41 PM EDT - Market open
Precigen Market Cap
Precigen has a market cap or net worth of $419.01 million as of March 31, 2025. Its market cap has increased by 10.73% in one year.
Market Cap
419.01M
Enterprise Value
336.89M
1-Year Change
10.73%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since August 8, 2013, Precigen's market cap has decreased from $2.32B to $419.01M, a decrease of -81.94%. That is a compound annual growth rate of -13.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 467.50M | 42.53% |
| Dec 31, 2024 | 328.00M | -1.68% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |